Clinical Trial Update: TBP Study With Capecitabine Plus Minus Trastuzumab [Phase 3]

View source ↗

Summary

A Phase 3 breast cancer trial evaluating capecitabine with and without trastuzumab has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: GBG Forschungs GmbH | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED